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W. J. FER~ELL AND K.-C. YAO. Metabolism of Palmitaldehyde in Human Cardiac Muscle. 
3ourml of Molecular and Cellular Cardiology (1976) 8, 1-13. Palmitaldehyde-1-r4[C] was 
incubated with homogenates of human heart and the distribution of radioactivity in the 
nonpolar and polar lipids was determined. Comparisons between the radioactivity in the 
acyl, alkyl and alk-I-enyl moieties were evaluated. The role ofpalmitaldehyde-[l-aH]-[l-r%] 
as a possible precursor of the alk-1-enyl chains was also assessed. A comparison of incorpora- 
tion into heart lipids was made between labelled palmitate, palmitaldehyde and cetyl 
alcohol. The following metabolic relationships are suggested from the results: 
1. Palmitaldehyde appears to be metabolized by a different route than palmitate 
and cetyl alcohol. 
2. Most of the incorporated palmitaldehyde was found in triglycerides indicating 
that the aldehyde was oxidized prior to incorporation. 
3. At least two pathways exist for the synthesis of alk-1-enyl ethers from aldehydes. 
One involves reduction to the alcohol and reaction with acyl-dihydroxyacetone phos- 
phate and the second, prior oxidation to the acid followed by incorporation, presumably 
through the 1-acyl linkage. 
4. Using the three labelled substrates led to an interrelationship which accounts for all 
three being incorporated into acyl, alkyl and alk-1-enyl chains. 
KEY WORDS: Metabolism; Heart; Palmitate; Palmitaldehyde; Cetyl alcohol; Plasmalo- 
gens; Alkyl ethers; Aldehydogenic lipid; Thin-layer chromatography; Gas-liquid 
chromatography. 
1. Introduction 
The existence of free fatty aldehydes as naturally occurring components of mam- 
malian heart muscle [S, IS, 17, 2.5] luminous bacteria [IT] and fruit lipids [IO, 281 
has been demonstrated in recent years. Fatty aldehydes serve as an intermediate 
in the oxidation level between the corresponding carboxylic acids and alcohols, 
and the enzymatic interconversion of fatty acids, aldehydes and alcohols has been 
shown [7, 12, 301. Other sources of free fatty aldehydes are reduction of the cor- 
responding fatty acyl-CoA [S, 171 and cleavage of the ether linkage of alk-I-enyl 
glycerol ethers and plasmalogens. 
The exact function of free fatty aldehydes in mammalian systems has yet to be 
established. In the light of our previous find that free fatty aldehyde concentration 
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increased with age in human heart [13] and serum [1.5] the present work dealing 
with the metabolism offree fatty aldehydes in human heart was undertaken. 
2. Materials and Methods 
Palmitic acid-[l-W] (53.3 mCi/mM) and cetyl alcohol-[l-r%] (11.4mCi/mM) were 
purchased from New England Nuclear Corp. and subjected to thin-layer chroma- 
tography (t.1.c.) before use. The liquid scintillation cocktail, Aquasol, was also 
purchased from New England Nuclear. All other chemicals used were of the 
highest possible purity. Cofactors were purchased from the Sigma Chemical Com- 
pany. Radiolabeled palmitaldehyde ([I-W], 1 .O mCi/mM) was synthesized as 
described elsewhere [14]. Palmitaldehyde-[I-sH]-[l-W] was prepared by LiAls 
[HI4 (4.4 mCi/mM, New England Nuclear Corp.), reduction of palmitic acid- 
[I-14C] (1.1 mCi/mM) [14]. 
The experiments were carried out in sucrose homogenates of human hearts 
obtained at autopsy and immediately frozen. The hearts were from male patients 
whose case histories and pathological evidence showed them to be free of myo- 
cardial infarction. The ages of the patients were 23, 39 and 59. Data on some of 
these hearts have already been given [13]. Two of the hearts (23 and 59) were from 
accident victims and the other was from a patient who died as a result of a brain 
tumor. All hearts were obtained within a few hours of death. Pericardial fat was 
removed and the tissue cut into small pieces which were centrifuged at 650 x g for 
20 min to remove cell debris and nuclei. The resulting supernatant was used for 
the metabolic studies. Incubations were carried out in 10 ml Erlenmeyer flasks 
using a Dubnoff metabolic shaker at 37°C and medium speed for 3 h (except for 
the time study experiments). Following incubation the mixtures were quantitatively 
extracted by the addition of 10 volumes of chloroform-methanol, 2: 1. A control 
was included in each experiment consisting of homogenate boiled for 30 min plus 
cofactors and substrate. Each incubation flask contained 0.3g of protein and 1 ml 
of radiolabeled substrate dispersed in 20 “/o aqueous Tween 20. Depending on the 
experiment, the incubation mixture also contained all or some of the following: 
1 ml 0.05~ Tris-HCl buffer, pH 7.0 NADH (1.5 PM), NADPH (1.5 PM), NAD 
(1.5 PM), ATP (3 PM), CoA (0.2 PM), KC1 (2.0 pM) and MgCls . 6HzO (1.0 PM). 
The total volume in all cases was 3 ml. 
Following extraction from the incubation mixture the lipids were concentrated 
under vacuum using a Buchii rotary evaporator. The lipids were blanketed under 
Nz and stored in fresh CS2 at -20°C until used [37]. The total lipids were separated 
into nonpolar and polar lipids [4] and aliquots removed for radio-assay and other 
analyses. The nonpolar lipids were further separated on a column (1.5 x 20 cm) 
of 200 to 325 mesh silicic acid. The column was thoroughly prewashed, before 
applying the samples, first with chloroform and then hexane. 
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The first fraction (a) containing long-chain hydrocarbons, wax esters and 
aldehydes was collected by elution with 200 ml of pure hexane; triglycerides (b) 
were collected with 200 ml of 2.5% diethyl ether in petroleum ether and the 
fraction (c) containing diglycerides, cholesterol, fatty alcohols and acids were 
collected by elution with 300 ml of chloroform. While this type of column separa- 
tion did not give pure lipid fractions it did serve to separate the major classes so 
that the small amounts of minor lipids could be subsequently obtained by t.1.c. 
Unless otherwise specified, neutral thin layer plates [29] of silica gel G were used 
after activation at 110°C for 2 h. Fractions (a) and (b) were separated into choles- 
terol esters, wax esters, free fatty aldehydes, alkyldiacylglycerides and triglycerides 
using a developing solvent of hexanediethyl ether (95:5, v/v) [27]. Fraction (c) 
was separated using plates of aluminum oxide H and double development in a 
solvent system of hexane-ethylacetate (160: 15, v/v) [IZ]. Free fatty aldehyde and 
acid fractions were further purified using hexane-diethyl ether-acetic acid (70: 30 : 1, 
v/v/v). Polar lipids were separated using chloroform-methanol-water (65 : 25 : 4, 
v/v/v) II331 *
For polar lipid samples subjected to reduction with either LiAlHa or vitride [3S] 
the products, consisting primarily of alk-I-enyl and alkyl glycerol ethers and fatty 
alcohols, were separated by t.1.c. using either diethyl-ether-water (100: 0.5 v/v) [36] 
or petroleum ether-diethyl ether-acetic acid (90: 10: 1 v/v/v) [Z?]. Prior to g.1.c. the 
fatty alcohols were converted to acetyl derivatives [3] and the 0-alkyl glycerol 
ethers were converted to their isopropylidene derivative [35]. The alk-I-enyl 
glycerol ethers obtained by reduction [3S] of the polar lipids were treated with 
HCI gas [9] and the liberated fatty aldehydes isolated by t.1.c. [9]. The fatty 
aldehydes were analyzed by g.1.c. [16]. 
Free fatty acids were methylated in sealed microflex tubes by heating for 1 h in 
a 100°C oven in the presence of 2 ml of methanol containing 2% sulfuric acid (v/v). 
The transmethylation of the nonpolar and polar lipid fractions was carried out as 
described by others [24]. To eliminate contamination with dimethyl acetals, free 
and bound fatty aldehydes were removed from both lipid fractions prior to methy- 
lation. The free aldehydes were removed by t.1.c. [IS] and the bound aldehydes 
also by t.1.c. following exposure to HCl gas [9]. 
G.1.c. analyses were carried out using a Packard, Model 7500 instrument with 
a flame ionization detector and a Model 850 fraction collector. A 6 ft glass column 
containing 14.5% EGSS-X on 100 to 120 mesh Gas-Chrom P (Applied Science) 
was used, with Ns as the carrier gas at a flow rate of 100 ml/min and an inlet 
pressure of 31 lbf/ins Ha and air flow rates were 300 ml/min and 220 ml/min 
respectively. Fatty aldehydes were run isothermally at either 160°C or 180°C. 
Fatty alcohol acetates and fatty acid methyl esters were run by programming from 
160°C to 190°C at a rate of 2’ per min. Peaks were identified by co-chromatography 
with known standards and from plots of chain lengths us the log of the relative 
retention time. Peak areas were calculated either as the product of the peak height 
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and the width at half peak height or by planimetry. Percentages are given in terms 
of peak areas. 
Samples analyzed by g.1.c. were collected, following separation, using the fraction 
collector. The gas stream emerging from the column was split in the ratio 10: 1 
(collector: detector). The hot effluent was trapped in short sections of glass tubing 
containing p-terphenyl crystals coated with DC-550 (Packard Instrument Co.). 
Each cartridge was then placed in a liquid scintillation counting vial, and 15 ml 
of scintillation cocktail, consisting of 4 g 2,5-diphenyl-oxazole (PPO) and 50 mg 1, 
4-bis [2-(4-methyl-5-phenyl oxazole)] benzene (dimethyl POPOP) in 1 1 of tolune, 
was added and the vials shaken vigorously. All samples were counted five times 
for 10 min in a Packard Tri-Carb, model 3320 spectrometer and the average value 
determined. Efficiencies and quench determinations, which were usually negligible, 
were made using an automatic external standard. Total recoveries of radioactivity 
from the g.1.c. column were between 70% and 800/,. Relative specific activities 
were taken as the ratio of the d/min in the collected fraction to the peak area of 
that fraction obtained during collection [I]. 
The radioassay of fatty acid methyl esters was also compared by monitoring the 
gas during analysis using a F&M Biochemical Gas Chromatograph Model 400 
equipped with a Barber-Colman Radio Activity Monitoring System Model 5190. 
The distribution of radioactivity among the various lipids was determined follow- 
ing t.1.c. by scraping the lipid zones into counting vials and adding 15-ml of 
Aquasol cocktail [ZO]. In the experiments using double labeled substrate, calcula- 
tions of radioactivity were made as described by Wagner et al. [33]. When both 
1% and sH were counted in the same sample eficiencies of 84% and 2676 respec- 
tively were obtained. 
Ester determinations were made as described by Rapport and Alonzo [Xl. Free 
and bound aldehydes were quantitated as hydrazones [8] and protein concentra- 
tions were determined by the Lowry method as modified by Miller [23]. 
Unless otherwise stated, all values reported are the average of at least three 
experiments using three different hearts. 
3. Results 
E$ect of incubation time 
The incorporation of radioactivity from palmitaldehyde-[l-i%] into heart lipids 
varied with time as shown in Table 1. The greater part ofthe incorporation appeared 
to be complete after 15 min and maximum incorporation became steady at 68% 
after 3 h. There was little effect of time on the distribution of radioactivity between 
the nonpolar and polar lipid fractions although a dramatic increase in total in- 
corporation was observed between 1.5 and 3 h. On the basis of these results all 
subsequent incubations were carried out for 3 h. 
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TABLE 1. Percentage and distribution of palmitaldehyde-[l-i%] * incorporated into 
human heart total lipid (TL), nonpolar lipid (NPL) and polar lipid (PL) after 




incorporation of radioactivity 
into TL$ % 












0.017 * 0.003 99.6 f 0.5 0.4 98.5 f 1.1 
0.821 + 0.46 89.3 + 2.2 10.7 97.3 -& 2.8 
1.40 & 0.31 79.4 * 1.7 20.6 101 f 1.1 
2.29 -& 0.24 68.1 * 1.4 31.9 92.5 f 2.6 
2.68 & 0.22 61.8 5 1.6 38.2 93.1 f 2.1 
2.57 h 0.19 70.5 f 1.2 29.5 100 f 1.2 
4.06 f 0.05 72.5 5 1.1 27.5 100 f 1.1 
4.03 + 0.04 65.4 i 1.1 34.6 92.0 f 2.8 
* Specific activity 1.0 mCi/mu. Incubations contained 0.3~ mol of labeled substrate. 
t Homogenate boiled for 30 min. 
$ Radioactivity recovered as starting precursor has been subtracted. 
Palmitaldehyde us palmitate or cetyl alcohol 
A comparison was made between the incorporation of radiolabeled fatty acid, 
aldehyde and alcohol into heart lipid. The results are given in Table 2. These 
results were rather surprising in that palmitaldehyde plus NAD or NADH was a 
TABLE 2. Percentage of palmitic acid-[l-W], cetyl alcohol-[l-W] and palmitalde- 














Palmitic acid-[ l -14C] t 




1.22 & 0.63 91.5 * 3.7 8.5 89.0 6 4.6 
1.31 * 0.47 88.1 f 2.9 11.9 100 f 1.1 
8.53 & 1.22 64.1 & 4.2 35.9 95.5 & 2.3 
10.78 & 1.54 66.1 f 3.8 33.9 100 f 1.2 
* Radioactivity recovered as starting precursor has been subtracted. 
t Specific activities: palmitic acid l.lmCi/mu; cetyl alcohol l.ZmCi/mu; palmitaldehyde 0.51 
mCi/mu. Incubations contained 0.1 TV mol oflabeled substrate. 
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much better precursor of heart total lipids than palmitic acid. Also, we see that 
with palmitaldehyde three to four times more incorporation was observed in the 
polar lipids than with either of the other substrates. The addition of unlabeled 
palmitate or cetyl alcohol (Table 3) caused a decrease in the incorporation of the 
radioactivity which could be attributed to the nonpolar lipids. 
TABLE 3. Incorporation of palmitaldehyde-[l-W], with added unlabeled palmitate and 
cetyl alcohol, into human heart lipids 
Addition to medium* 
Incorporation 
into TLt (%) 
Distribution of Total 
radioactivity (%) radioactivity 
NPL PL recovered (%) 
Palmitaldehyde-[1-14C]$ 






Cetyl alcohol (20 mg) 
o/0 Change 
84.7 $ 2.1 71.3 f 1.9 28.7 94.8 & 2.3 
66.2 * 3.7 62.5 & 2.6 37.5 96.6 + 3.7 
-18.5 f 1.6 -8.8 * 0.7 +8.8 
71.8 f 2.4 61.6 f 1.7 38.4 100 & 1.1 
-12.9 i 0.3 -9.7 f 0.2 $9.7 
* The medium also contained NADH, CoA, ATP, KCL and MgCla. 
t Radioactivity recovered as starting precursor has been subtracted. 
$ Specific activity 1 .O mCI/mn. Incubations contained 0.3 mol of labeled substrate. 
Palmitaldehyde incorporation into lipids 
When the nonpolar and polar lipid fractions from 3 h palmitaldehyde-[I-%] 
incubations were separated into their components the results given in Table 4 were 
obtained. Only fractions containing 2% or greater of the incorporated activity are 
reported. Most of the incorporation occurred in the triglyceride fraction. Thus, it 
would appear that the palmitaldehyde had been incorporated following enzymatic 
oxidation. This is further supported by the incorporation into free fatty acids, 
cholesterol esters and the phosphoglycerides. 
When similar experiments were carried out using palmitate-[PC] and cetyl 
alcohol-[l-r%] we found slight incorporation from palmitate into free fatty alde- 
hydes, however, no radioactivity was ever detected in this lipid fraction when cetyl 
alcohol was used as substrate. 
Incorporation into acyl, alkyl and alk-1-enyl chains 
The distribution of radioactivity into the acyl, alkyl and alk-1-enyl moieties of the 
polar lipids was determined following reduction with vitride [36] and isolation of 
the above reduction products by t.1.c. [22, 361. The effects of various coenzymes as 
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TABLE 4. Incorporation of radioactivity from palmitaldehyde-[l-r%] into various lipid 
classes by heart homogenates* 
Fraction Lipid class d/min x 10s Distribution (%) 
Free fatty acid 284 & 46 7.0 * 0.4 
Triglyceride 2080 * 172 51.2 f 2.2 
NPL Glycerol ether diesters 134 f 31 3.3 f 0.3 
Cholesterol ester 345 5 53 8.5 f 0.3 
Other NPL 101 f 28 2.5 f 0.4 
Choline phosphoglyceride 353 f 48 8.7 f 0.1 
PL Ethanolamine phosphoglyceride 483 f 51 11.9 & 0.9 
Serine phosphoglyceride 85 f 18 2.1 f 0.3 
Other PL 203 f 80 5.0 f 1.3 
* Incubations were for 3 h at 37°C using pamitaldehyde with a specific activity of 1.0 mCi/mM. 
The incubation medium also contained CoA, ATP, NADH, NAD, MgCls and KC1 (See text for 
amounts). Results represent the average of four experiments. 
well as a comparison between palmitate, palmitaldehyde and cetyl alcohol as 
potential precursors were evaluated using a 3 h incubation. These results are 
presented in Table 5. In all cases the largest proportion of the radioactivity was 
TABLE 5. Distribution of radioactivity among acyl, alkyl and alk-1-enyl moieties of polar lipids (PL) 





(d/mm x Acyl Akyl Alk-1-enyl 
102) (d/mm x lOsratio)$ (d/min x lOsratio)$ (d/min x 10sratio)f 
None 546f32 340+26 - 31f8 - 25*4 - 
NAD 1838&94 1440*143 4.2 93-+4 3.0 68&9 2.7 
NADH 3038& 103 1917*184 5.6 297*32 9.5 285k43 11.4 
NADPH 1632+ 155 899k96 2.6 236*43 7.6 221236 8.8 
NADH + CoAt 793+81 487&56 1.4 751-g 2.4 68*9 2.7 
NADH + CoAt 
+ 2563+147 1666+122 4.9 89+7 2.9 66*8 2.6 
Palmitic acid (20mg) 
NAD + CoAt 
Cetyl &oh01 (20mg) 
2867&134 1777+156 5.2 393+87 12.7 97*9 3.9 
* Incubations were for 3 h at 37°C using 0.3 pmol of palmitaldehyde-[l-14C], specific activity 
1 .O mCi/mhi. 
t The medium also contained ATP, KCl, MgCls. (See text for amounts.) 
t d/min with additiontd/min no addition. 
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found in the acyl chains of the polar lipids. The proportion of radioactivity in both 
the alkyl and alk-I-enyl chains increased about nine-fold in the presence of NADPH 
and about ten-fold with NADH, however, with NADH plus CoA and other co- 
factors the increase was only about three-fold. CoA appeared to inhibit the in- 
corporation of aldehyde into acyl chains. The addition of excess unlabeled palmitate 
to the NADH plus CoA had little effect on the proportion of radioactivity in the 
alkyl and alk-1-enyl chains but did allow more aldehyde to be incorporated into 
acyl chains. Excess unlabeled cetyl alcohol also gave an increase in incorporation 
into all the fatty chains although the most dramatic effect was on the alkyl groups. 
The effect of added unlabeled palmitate or cetyl alcohol was evaluated more 
directly by g.1.c. The 16: 0 component of the various fatty moieties was collected 
and the relative specific activity determined. These results are given in Table 6. 
TABLE 6. Effect of palmitate and cetyl alcohol on the incorporation of palmitaldehyde- 
[l-W] into the 16:0 component of various fatty chains 
Relative specific activity of 16:0 moiety 
Free Free Free* Acyl Alkyl Alk-1-enyl 
Condition acid aldehyde alcohol NPL PL NPL PL NPL PL 
Palmitaldehyde- 
[l-‘4C] 7.7 20.3 4.8 53.2 18.2 10.2 8.1 11.3 17.8 
Palmitaldehyde- 
[l-W] -t 18.9 4.7 3.6 7.5 6.7 4.9 6.1 10.2 
+ 
Palmitate 
Change (%I -7 -2 -93 -59 -34 -39 -46 -43 
Palmitaldehyde- 
[l-W] 3.6 20.9 -7 26.9 19.0 5.4 3.6 3.8 4.5 
+ 
Cetyl alcohol 
Change (%I -53 0 -49 +4 -47 -56 -66 -75 
* UnIalxled cetyl alcohol added as carrier following incubation. 
t Not determined due to added unlabeled precursor. 
The relative specific activity of the latter was essentially unchanged by the addition 
of unlabeled 16: 0 acid. The relative specific activity of the 16: 0 aldehyde did not 
change significantly by the addition of either unlabeled 16: 0 acid or alcohol. These 
results suggest that the equilibrium lies away from the aldehyde towards either the 
acid or alcohol. 
The dilutions in radioactivity of the 16 : 0 component of the acyl, alkyl and alk-l- 
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enyl moieties following the addition of cetyl alcohol or palmitate suggest that they 
are being used competitively with the aldehyde for the biosynthesis of these lipid 
chains, or that they are competing for a necessary cofactor. 
To further answer this question the incubations using palmitaldehyde-I-sH-[I-W] 
were made. Following incubation, at two different times, the sH:W ratios of the 
polar lipid acyl, alkyl and alk-l-enyl chains were determined. These results are 
given in Table 7. As expected most of the sH was lost in the acyl groups but only 
TABLE 7. Comparison of sH :14C ratios of acyl, alkyl and alk-I-enyl moieties of polar lipids 














* 3H:l*C ratio ofsubstrate was 3.9. 
about 50% loss of sH occurred in the alk-I-enyl chains. Thus fatty acids appear to 
play some role in the biosynthesis of the alk-I-enyl bond of plasmalogens or a 
greater percentage of sH should have been lost. Since approximately 80% of the 
sH was retained in the alkyl ether moieties, it is suggested that aldehydes are 
primarily reduced to alcohols prior to incorporation into 0-alkyl glycerol ethers. 
4. Discussion 
The time study (Table 1) shows that maximum incorporation of palmitaldehyde- 
[I-W] occurred after 3 h. Using this time, two other precursors, palmitate-[I-W] 
and cetyl alcohol-[I-W], were also studied. It was found that palmitaldehyde- 
[I-i4C] was incorporated into lipids to a greater extent than either of the other 
substrates (Table 2). However, it should be recognized that this may be true only 
for the 3 h incubation time, since a complete time study was not performed on the 
other substrates. In mouse liver, for example, maximum interconversion of fatty 
acids, aldehydes and alcohols occurred in less than 1.5 h, when starting with 
radiolabeled palmitate [I.?]. 
The greater incorporation of palmitaldehyde over palmitate or cetyl alcohol 
(Table 2) and the competitive experiment (Table 3), would suggest that there 
exists a metabolic pathway for fatty aldehydes different from that of the acid or 
alcohol in addition to those pathways which may be the same. When 20 times as 
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much unlabeled palmitate or cetyl alcohol was added to the incubation media 
containing labeled palmitaldehyde the change in either the total incorporation of 
the aldehyde or in the distribution of the incorporated activity between nonpolar 
and polar lipids, was not as great as one would expect if only metabolic pathways 
which were the same for all three compounds existed or they were operating 
through a common intermediate. 
Radioactivity from palmitaldehyde-[l-r%] was incorporated into nonpolar and 
polar lipids with results similar to that observed by others in Ehrlich ascites cells [38]. 
Our studies indicate that most of the radioactivity from palmitaldehyde was found 
in lipids containing ester linkages (Table 4). Radiolabeled free fatty acids were 
isolated, but only very small percentages of radiolabeled free fatty alcohols were 
detected. Thus it appears that pahnitaldehyde was primarily converted to fatty 
acid and to only a small extent reduced to alcohols. This is also shown by the data 
in Table 5 using various cofactors. When excess cold palmitate was added to 
incubations containing labeled palmitaldehyde it was primarily the incorporation 
into the acyl groups which was affected. 
The slight incorporation of palmitate-[l-1%] into free fatty aldehydes and the 
lack of incorporation of cetyl alcohol-[l-l%] into free fatty aldehydes suggests that 
in human heart the interconversion among these three lipids is as follows : 
R-COsH +---- RCHO +;-I- R-CHaOH 
This is different from that proposed for either mouse preputial gland tumors [30] 
or normal mouse liver [12], and the reason may well be the absence of alcohol 
dehydrogenase in heart muscle [21]. 
In Ehrlich ascites cells it was shown that fatty acids were precursors of long 
chain alcohols which were then incorporated in alkyl glycerol ethers [38]. These 
alkyl glycerol ethers were then found to be precursors of the alk-I-enyl glycerol 
ethers. Our experiments here support this idea. For example, first we see in Table 5 
that in all cases the radioactivity of the alkyl ethers is greater than that of the 
alk-I-enyl ethers. That in heart tissue there is ten times more alk-I-enyl than alkyl 
ether [Ia] adds even more significance to the radioactivity data. Secondly, the 
experiments with the double labeled palmitaldehyde (sH and 1%) would further 
suggest a similar system in human heart. However, the fact that only 50% loss of 
sH occurred in the alk-I-enyl chains also suggests an alternate pathway involving 
fatty acids directly, perhaps by reduction of the Lacy1 moieties as suggested by 
others [I]. 
The evidence here does, however, argue against those mechanisms suggested by 
Bell and White [2] and Carr et al. [.5]. Bell and White [2] showed that, in the 
developing rat brain, long chain aldehydes are direct precursors of the alk-I-enyl 
linkage and that oxidation to the acid is not a prerequisite. Carr et al. [5], also 
working with rat brain, found that palmitaldehyde was not incorporated into the 
plasmalogen ether linkage, but that palmitate and stearate were incorporated to a 
limited extent. 
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Comparison of the data from Tables 5 and 7 could lead to contradictory results. 
In Table 5 since the incorporation into alkyl ethers from palmitaldehyde-[l-W] + 
NADH + CoA is increased by adding cold excess cetyl alcohol it would appear 
that cetyl alcohol is an unlikely precursor of the alkyl chain. Conversely, from the 
same Table, the incorporation into the aldehydogenic linkage also drops. One 
might interpret this as a cetyl alcohol requirement for the aldehydogenic linked 
chain but not for the saturated alkyl ether. However the experiments (Table 7) 
with the double labeled palmitaldehyde say that cetyl alcohol is incorporated into 
both ether moieties. One possible explanation is that in the experiment with excess 
cold cetyl alcohol we are seeing the results of an equilibrium between the cold 
alcohol and labeled aldehyde to give an aldehyde pool of lesser specific activity. 
Furthermore, this equilibrium occurs at a faster rate than does the incorporation of 
the alcohol into alkyl ethers. 
Since it has been established that alkyl glycerol ethers are synthesized by an 
exchange between long chain fatty alcohol and acyl-dihydroxyacetone phosphate 
[32] the source of the fatty alcohols becomes important. The incubations involving 
palmitaldehyde-[I-sH]-[l-W] showed that about 80% of the sH was found in the 
alkyl ethers. Thus reduction of the aldehyde to the alcohol may be an important 
pathway. That cardiac muscle has the ability to reduce fatty acids to fatty alde- 
hydes has already been demonstrated [7,19]. 
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